Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple System Atrophy, MSA”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Not applicableStudy completedNCT05011773
What this trial is testing

Manipulating and Optimising Brain Rhythms for Enhancement of Sleep

Who this might be right for
Parkinson DiseaseMSA - Multiple System AtrophyChronic Pain+1 more
University of Oxford 4
Not applicableStudy completedNCT06204575
What this trial is testing

Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkinsonism

Who this might be right for
Atypical ParkinsonismDementia With Lewy BodiesMultiple System Atrophy, MSA
Rambam Health Care Campus 8
Not applicableLooking for participantsNCT02194816
What this trial is testing

Modifiable Variables in Parkinsonism (MVP)

Who this might be right for
Parkinson's DiseaseParkinsonismMSA - Multiple System Atrophy+6 more
Bastyr University 2,000
Testing effectiveness (Phase 2)Ended earlyNCT05695378
What this trial is testing

Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy
Kainos Medicine Inc. 68
Not applicableStudy completedNCT01485549
What this trial is testing

Oligomeric Alpha-synuclein in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
University Hospital, Bordeaux 48
Not applicableStudy completedNCT00743561
What this trial is testing

Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA)

Who this might be right for
Sleep Apnea SyndromesMultiple System Atrophy
University Hospital, Bordeaux 30
Testing effectiveness (Phase 2)Looking for participantsNCT06831500
What this trial is testing

Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.

Who this might be right for
Multi-system Atrophy - Parkinsonian TypeOrthostatic Hypotension, DysautonomicParkinson Disease
Julien Bally 36
Very early researchStudy completedNCT04616456
What this trial is testing

Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients

Who this might be right for
Multiple System AtrophyMultiple System Atrophy, Cerebellar VariantMultiple System Atrophy, Parkinson Variant (Disorder)+1 more
Brigham and Women's Hospital 19
Not applicableLooking for participantsNCT04782284
What this trial is testing

Comprehensive Swallowing Rehabilitation in Patients With MSA

Who this might be right for
Multiple System Atrophy
Seoul National University Hospital 24
Not applicableActive Not RecruitingNCT05792332
What this trial is testing

Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)

Who this might be right for
Atypical ParkinsonismMSA - Multiple System AtrophyPSP+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 164
Not applicableUnknownNCT04313530
What this trial is testing

TMS Treatment in Multiple System Atrophy With Fatigue

Who this might be right for
Transcranial Magnetic StimulationMultiple System AtrophyFatigue
Xuanwu Hospital, Beijing 22
Large-scale testing (Phase 3)Active Not RecruitingNCT05696717
What this trial is testing

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSA - Multiple System Atrophy
Theravance Biopharma 102
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Early research (Phase 1)Active Not RecruitingNCT05698017
What this trial is testing

Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)

Who this might be right for
Multiple System AtrophyMSA - Multiple System Atrophy
Cytora Ltd. 10
Very early researchLooking for participantsNCT07640542
What this trial is testing

Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase

Who this might be right for
Parkinson Disease (PD)MSA - Multiple System AtrophyHealthy Adult Participants
MODAG GmbH 9
Large-scale testing (Phase 3)Looking for participantsNCT07446894
What this trial is testing

MSA-01 in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Tokyo University 140
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Not applicableLooking for participantsNCT02795052
What this trial is testing

Neurologic Stem Cell Treatment Study

Who this might be right for
Neurologic DisordersNervous System DiseasesNeurodegenerative Diseases+23 more
MD Stem Cells 500
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT05923866
What this trial is testing

ONO-2808 in Patients With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Ono Pharmaceutical Co., Ltd. 92
Next Page